Shield AI closed a $1.5 billion Series G at a $12.7 billion post-money valuation on March 26, 2026 – figures Reuters’ own March 2026 report independently confirmed – a 140% leap from the $5.3 billion mark the San Diego defense startup carried after closing its Series F-1 on March 6, 2025, a jump TechCrunch’s own March 2026 coverage likewise verified; though Yahoo Finance’s own reporting on the round, which likewise confirmed the $1.5 billion raise at a $12.7 billion valuation, anchored that same 140% climb to a December 2023 baseline rather than the March 2025 mark, a reminder that outlets have not converged on a single timeline for the run-up. The round, led by Advent International and co-led by JPMorganChase’s Security and Resiliency Initiative, lands alongside an additional $500 million in fixed-return preferred equity from Blackstone and a $250 million delayed draw facility, pushing the total capital event to roughly $2.25 billion as of March 2026 – a package size Angel Investors Network’s own tally of the deal independently corroborated, even as Shield AI’s own official announcement rounded the combined new capital to a flat $2 billion – though Reuters, in its own account of the deal terms, pegged the core raise at $2.0 billion when combining the $1.5 billion equity tranche with Blackstone’s preferred stake. The proceeds are earmarked for two purposes: scaling the V-BAT autonomous aircraft and the Hivemind autonomy stack, and bankrolling the planned acquisition of Aechelon Technology, the simulation and synthetic-environment vendor that powers the U.S. Air Force’s Joint Simulation Environment.
The capital injection arrives weeks after the U.S. Air Force selected Hivemind as a software provider for the Collaborative Combat Aircraft (CCA) program, a generational bet on autonomous wingmen flying alongside crewed F-35s and the forthcoming F-47. With Shield AI funding now eclipsing $3.6 billion in lifetime equity and projected 2026 revenue of more than $540 million, the company is no longer the scrappy underdog to Anduril Industries. It is the second pillar of America’s autonomy-first defense industrial base – and the rare private-market story where a 50% trailing search volume gain on the brand name is matched by a real production backlog rather than hype. That backlog is visibly converting into fielded, allied-facing work: as recently as September 2026, Shield AI showcased an upgraded V-BAT variant configured for UAE maritime missions, Army Recognition reported, extending the aircraft’s footprint well beyond the U.S. services that first fielded it.
Don't miss new tech stories on Google
Add Tech Insider once in the Google app and our stories appear in your news suggestions.
Shield AI Series G: The $12.7 Billion Headline Numbers
The March 26 announcement is unusual in defense tech for how cleanly the math lays out. Shield AI’s own disclosure put the Series F-1 at $240 million, closed March 6, 2025, at a $5.3 billion valuation. Twelve months later, that valuation hit $12.7 billion – a figure Reuters’ own March 2026 coverage corroborated – a 140% increase between the March 2025 and March 2026 marks that Angel Investors Network’s own tracking of the deal independently confirmed, and one that outpaces the broader VC-backed defense sector and rivals what AI software companies posted during the 2023–2024 generative AI boom. Sacra’s own tracking tells a slightly different version of that same run-up: as of March 2025 it had Shield AI’s cumulative Series F-1 funding at $540 million against a $5.6 billion valuation, a broader tally than the single-round $240 million at $5.3 billion Shield AI’s own press release cited. Importantly, the Series G is structured as primary capital, not a tender offer. That distinction matters: the cash hits the balance sheet rather than rotating shares between funds, which means Shield AI can deploy it directly into V-BAT production lines, the Aechelon integration, and the new combat drone the company says will fly before year-end.
The capital stack is layered. Advent International, the Boston-based private equity firm with roughly $94 billion in assets under management, anchored the equity tranche. JPMorganChase’s Security and Resiliency Initiative – the bank’s $10 billion commitment announced in 2025 to back U.S. and allied defense, energy, and critical-mineral firms – co-led. Blackstone added $500 million in preferred equity carrying a fixed return, and a $250 million delayed-draw facility gives Shield AI optionality to pull additional capital as the Aechelon close approaches; Bloomberg’s March 26, 2026 reporting confirmed that precise split of $1.5 billion in equity plus $500 million in preferred, matching the structure Shield AI disclosed, while Fortune’s own account of the financing likewise verified the $500 million preferred tranche but rounded the combined raise to a flat $2 billion rather than itemizing the separate delayed-draw facility. Notably, the final tranche of the round is contingent on regulatory approval of the Aechelon acquisition, signaling that Advent and JPMorgan want to underwrite the integrated entity, not just the standalone product company.
Board composition reflects the seriousness of the financing. Advent Chairman David Mussafer joined Shield AI’s Board of Directors. JPMorgan’s Todd Combs – Berkshire Hathaway investor and head of Geico, who also sits on JPMorgan’s strategic investments group – joined as a Board Observer. Combs’s presence sends a clear signal: institutional capital, not just venture capital, is now setting valuation expectations for the autonomous-systems category.
How the $1.5B Round Compares to Anduril and the Defense AI Pack
Shield AI’s Series G needs to be benchmarked against the defining defense-tech story of the past two years: Anduril Industries’ march toward a $60 billion-plus valuation. Anduril raised $2.5 billion at a $30.5 billion valuation in June 2025, then closed a $500 million Series G-1 on January 14, 2026, at a $37.95 billion mark. By March 2026, secondary-market reports valued Anduril near $84.5 billion, and the company is reportedly in talks for fresh primary capital co-led by Thrive Capital and Andreessen Horowitz at a $60 billion-plus valuation. Anduril’s 2025 revenue reached approximately $2.15 billion, up 115% year-over-year.
The two companies are now structurally interlinked rather than purely competitive. Anduril is building the airframe for Increment 1 of the Air Force’s CCA program – its YFQ-44A “Fury” autonomous fighter – while Shield AI’s Hivemind was selected in February 2026 to provide the autonomy software stack for the same prototype. In effect, Anduril supplies the body and Shield AI supplies the brain. That partnership is reshaping how investors think about the moat. Anduril’s pitch is vertical integration; Shield AI’s pitch is software portability across third-party hardware. Both can be true, and both can be underwritten by the same DoD budget cycle.
| Metric | Shield AI (Mar 2026) | Anduril (Jan 2026) | Palantir (Public) | Helsing (Jul 2025) |
|---|---|---|---|---|
| Latest valuation | $12.7B post-money | $37.95B primary | ~$190B market cap | $5.4B (€5B) |
| Latest round size | $1.5B Series G | $500M Series G-1 | Public (NYSE: PLTR) | $693M Series D |
| Total equity raised | ~$3.6B | ~$6.9B | ~$3.0B pre-IPO | ~$1.4B |
| 2025 revenue | ~$300M (est.) | $2.15B | $2.87B | ~$200M |
| 2026 revenue target | $540M+ | $3B+ | $3.7B+ (guidance) | Not disclosed |
| Lead product | V-BAT, Hivemind | YFQ-44A Fury, Lattice | Foundry, AIP, Maven | Centaur, HX-2 |
| Headcount (approx.) | ~1,200 | ~5,000 | ~3,800 | ~700 |
The valuation gap between Shield AI and Anduril – roughly 3x – is narrower than the revenue gap, which is closer to 7x. That tells you the market is pricing Hivemind as a software multiple, not a defense-prime multiple. If the CCA contract progresses to Increment 2 and Shield AI’s autonomy stack runs on additional airframes, the revenue gap compresses faster than the valuation gap, which is precisely the scenario Advent and JPMorgan underwrote.
The Aechelon Acquisition: Why Simulation Is the Hidden Moat
Roughly $500 million of the new capital is allocated to the Aechelon Technology acquisition, the deal that triggered the entire transaction. Aechelon, founded in 1998 and headquartered in San Francisco, builds the high-fidelity image generators and physics-based sensor models that train pilots and autonomous systems alike. Its software underpins the Pentagon’s Joint Simulation Environment (JSE) – the same facility used to validate the F-35 and now the CCA program – along with full-mission simulators for the Navy and Air Force. In autonomous-systems engineering, simulation is not optional. Every flight hour in the real world costs tens of thousands of dollars; every flight hour in a sim costs cents. Owning the simulator that the customer uses to certify your software is the most defensible moat in defense AI.
“Aechelon’s high-fidelity, physics-based simulation is the bridge between training pilots, training autonomy, and certifying weapons systems,” Brandon Tseng, Shield AI’s co-founder and president, said in the March 26 announcement. The integration roadmap is straightforward: Aechelon’s synthetic environments will be wired directly into Hivemind’s training pipeline, allowing the autonomy team to generate millions of synthetic flight hours per week against scenarios that mirror Pentagon test conditions. That throughput is what separates a credible CCA bidder from a research project.
The acquisition also gives Shield AI a recurring software-license stream from existing Aechelon customers – the Navy, Air Force, allied air arms, and prime contractors who buy seats for full-mission simulators. That revenue is sticky, multi-year, and gross-margin-positive in a way the V-BAT hardware business cannot match. Bankers who saw the deal book describe Aechelon’s revenue as “high two-figure millions” with software-grade margins, which would meaningfully improve Shield AI’s blended gross margin profile heading into a future IPO.
Hivemind: The Autonomy Software Driving the Story
Hivemind is Shield AI’s flagship autonomy platform – the operating system that lets aircraft, ground vehicles, and surface vessels operate without GPS, communications, or remote pilots. The company calls it “the world’s only AI pilot,” a marketing line that obscures the more interesting technical reality: Hivemind is a stack of perception, planning, and reinforcement-learning modules trained against simulated and real-world flight data, then deployed onto edge compute inside the airframe. It has been integrated onto the V-BAT, the F-16 (in the VENOM-AX program), and the MQ-20 Avenger, among others – Shield AI’s own March 2026 tally puts Hivemind’s pilot footprint at 26 distinct vehicle classes – and is the autonomy provider for Anduril’s Fury under the CCA Increment 1. Hivemind’s commercial traction is already visible in the top line rather than confined to press releases: Sacra estimated the software stack accounted for roughly 30% of Shield AI’s total revenue as of March 2025, evidence that the autonomy layer is generating recurring, program-linked dollars well ahead of the CCA award.
The CCA selection in February 2026 is the strategic prize. The Air Force has stated it intends to procure between 1,000 and 1,500 collaborative combat aircraft over the program’s life, at a target unit cost roughly one-quarter of an F-35. If Hivemind ships on even a third of those airframes, the lifetime software revenue exceeds anything Shield AI has visibility on today. That is the option value Advent and JPMorgan are buying – not the V-BAT order book, which is real but bounded.
V-BAT Specs and Production Trajectory
The V-BAT is the cash cow that funded the autonomy ambition. It is a vertical-takeoff, ducted-fan tactical UAS with a roughly 11-hour endurance, an operating ceiling above 20,000 feet, and a payload bay engineered for swappable EO/IR, SIGINT, and strike packages. Shield AI rolled out a block upgrade to the platform in April 2025, adding satellite communications and a heavy-fuel engine to extend range and simplify logistics for shipboard and expeditionary operators, and by July 2025 the resulting V-BAT 5.3 variant had reportedly met 100% of its key performance requirements in testing. The aircraft is in service with U.S. Special Operations Command, the U.S. Coast Guard, the Department of Homeland Security, and an undisclosed list of foreign militaries. Brandon Tseng told reporters that V-BAT is “operating in almost every single conflict zone,” declining to confirm whether the system has been deployed in Iran. Shield AI is also developing the X-BAT, a VTOL fighter jet the company unveiled in October 2025, with initial flights planned for 2026 and operational validation targeted for 2028 – a clear signal the company is moving up-market into the strike segment dominated by reusable loitering munitions.
The Air Force CCA Program: Where the $12.7B Valuation Comes From
Strip away the press-release language and the Series G is, fundamentally, a bet on the Collaborative Combat Aircraft program. Increment 1 awarded prototype contracts to Anduril (YFQ-44A) and General Atomics (YFQ-42A) in 2024, with first flights expected in 2026. The Air Force’s stated goal is fielded combat capability before 2029, which means software selection decisions made in 2025–2026 lock in the autonomy provider for at least a decade of acquisition cycles. Hivemind beating out internal Air Force candidates and rival commercial offerings to be selected on the Fury was the inflection point that compressed the funding timeline.
The Pentagon’s FY2026 budget request includes roughly $8.9 billion for autonomous and collaborative platforms across the services, with CCA representing the single largest line item at approximately $1.0 billion in Air Force RDT&E. The Replicator initiative, the OSD-led effort to field thousands of attritable autonomous systems by mid-2026, is funded at approximately $1.0 billion across two tranches and has explicitly identified V-BAT as a Replicator-eligible system, a designation the platform reinforced when its upgraded V-BAT 5.3 variant reportedly cleared 100% of its key performance requirements in July 2025 testing. Together, the CCA and Replicator pipelines define a procurement environment Shield AI is positioned to win against, and the Series G gives it the working capital to scale production rather than queue for milestone payments.
What the Money Means for Shield AI’s Revenue Path
Shield AI is projecting more than 80% revenue growth in 2026, equating to “at least $540 million,” according to Fortune’s reporting on the round. That implies a 2025 baseline of roughly $300 million – a figure Sacra pegged precisely for the year ending March 2025, up from $267 million in 2024 – a 2024 figure NewMarketPitch’s March 2026 data set corroborated alongside Sacra’s own numbers – and one PMInsights corroborated in a May 2026 report putting 2025 revenue at $300 million, a 12.36% year-over-year increase – a figure Powerlaw’s own August 2026 analysis landed on as well, pegging 2025 revenue at roughly $300 million. Hustle Fund’s August 2026 retrospective traced the climb back further still, putting Shield AI’s fiscal 2023 revenue at roughly $163 million before it very nearly doubled to that $300 million mark by March 2025. The trajectory matters because defense-tech revenue does not scale linearly. It scales in step-function jumps that mirror program-of-record awards – a pattern Anduril rode from $200 million in 2022 to $2.15 billion in 2025. If Shield AI hits the $540 million target and converts the CCA software pipeline into a multi-year program-of-record line, the company is on a credible path to $1.5 billion-plus in 2027 revenue.
| Round | Date | Amount | Valuation | Lead investor |
|---|---|---|---|---|
| Seed | 2017 | $10.5M | ~$40M | Andreessen Horowitz |
| Series A | 2018 | $20M | Undisclosed | Bloomberg Beta |
| Series B | 2019 | $47.5M | ~$165M | Riot Ventures |
| Series C | 2020 | $90M | ~$310M | Riot, Snowpoint |
| Series D | 2021 | $210M | ~$1.0B (unicorn) | Disruptive |
| Series E | 2022 | $165M | ~$2.3B | Snowpoint Ventures |
| Series F | 2024 | $300M | ~$2.8B | Riot, US Innovative Tech |
| Series F-1 | Mar 2025 | $240M | $5.3B | L3Harris, Hanwha |
| Series G | Mar 2026 | $1.5B | $12.7B | Advent, JPMorganChase SRI |
The total of approximately $3.6 billion in equity raised across the company’s life – Tracxn’s tally of disclosed rounds put the figure above $3 billion as of March 2026, ahead of the Series G’s full accounting, while TSG Invest’s independent count as of March 2025, taken before the Series G closed, had Shield AI’s balance sheet at $1.4 billion in cumulative equity plus $200 million in debt financing – is high by software-startup standards but conservative by defense-prime standards. Lockheed Martin’s R&D budget alone exceeds Shield AI’s lifetime fundraising every year. The bull case is that Shield AI builds the OS layer for autonomous defense; the bear case is that the primes – Lockheed, Northrop, RTX – replicate Hivemind in-house with their own data, and the Series G valuation discounts a software-monopoly outcome that never arrives.
Defense Tech Funding 2026: A Sector Repriced
Shield AI’s round caps a 12-month repricing of the defense-tech category. According to Crunchbase data, defense-related startup funding crossed $4.5 billion in Q1 2026 alone, a record quarter that includes Shield AI’s $1.5 billion, Anduril’s $500 million Series G-1, and roughly a dozen smaller checks into autonomy, space, and cyber. That figure does not capture the secondary-market activity at Anduril or the unannounced extensions at Helsing in Europe, which would push the all-in number closer to $7 billion if those rounds clear in the coming weeks.
The repricing is structural, not cyclical. Three forces are pulling capital into the sector: (1) the war in Ukraine has demonstrated, at scale, that mass-produced low-cost autonomous systems beat exquisite legacy platforms in attritional warfare; (2) the U.S.-China rivalry has elevated autonomous combat aircraft from a research program to a near-term acquisition priority; and (3) the entire commercial AI capability stack – sensors, edge compute, transformers, RL – has matured to the point where defense applications can absorb it without bespoke chip development. Shield AI sits at the intersection of all three forces.
The IPO Question
The Series G is not an IPO bridge in the traditional sense – there is no public guidance on a listing – but the structure makes one easier when the window opens. Advent and JPMorgan as anchors are textbook crossover investors, the kind who hold private positions through a public listing. Aechelon’s contribution to gross margin and the Hivemind contribution to the revenue mix are the two variables underwriters will watch most closely. If the company maintains 80%+ growth into 2027 and the CCA contract converts to a program of record, a 2027 listing at a $25–30 billion valuation is plausible. The reference comparable will be Palantir, which today trades at roughly 60x forward revenue – a multiple Shield AI would need to grow into rather than match on day one.
Historical Context: From Quadcopters to Autonomous Wingmen
It is worth remembering where Shield AI started. Brandon Tseng, a former Navy SEAL, and his brother Ryan Tseng, an electrical engineer, founded the company in 2015 around the Nova quadcopter – an indoor reconnaissance drone designed to clear buildings without a human operator. The original product was small, scrappy, and used by special operations teams. Hivemind began as the autonomy stack for Nova; only later did it become a portable software product. The decision to abstract the autonomy from the airframe is the single strategic choice that built the $12.7 billion company. It mirrors what Microsoft did with Windows on PCs and what Android did with mobile – separate the OS from the hardware, and let the OS spread.
The company’s evolution from indoor drone vendor to autonomous combat aircraft software provider compressed into roughly a decade. The pivot points are visible in the funding history above: Series D in 2021 unlocked V-BAT scale production; Series F in 2024 funded the Hivemind productization; the Series G is funding the Aechelon integration and the leap into the combat segment. The next pivot – a true tactical-strike autonomous platform – will likely be the Series H or the IPO.
What Wall Street and Defense Analysts Are Saying
The reaction across institutional research has been notably bullish on the autonomy thesis but cautious on individual valuations. “The defense AI category is now structurally a software market with hardware attached, not the reverse,” said Byron Callan of Capital Alpha Partners, a defense industry veteran whose notes have circulated since the announcement. “Shield AI’s CCA selection is the kind of program win that justifies a step-up multiple.”
Other observers have flagged execution risk. “Twelve-point-seven billion is priced for a clean Aechelon close, the CCA contract converting to production, and Hivemind appearing on a third platform within 18 months,” wrote Roman Schweizer, defense analyst at TD Cowen, in a client note. “Miss any one of those and the next round is flat at best.” David Mussafer, the Advent chairman who joined Shield AI’s board, framed the round in different terms in the company’s release: “We see Shield AI as a foundational platform for autonomous defense systems, with the technical depth and program traction to capture a generational market.”
Brandon Tseng’s own framing emphasized scale rather than ambition: “This funding accelerates our path to being the autonomy provider for every CCA airframe, every loyal wingman, and every attritable system the Department of Defense fields this decade.” Whether that line is read as confidence or hubris will depend on the program-of-record awards still to come in FY2027 budget negotiations.
Five Predictions for Shield AI Through 2027
1. Aechelon clears regulatory review by Q3 2026. The acquisition is structured as a private-to-private all-stock-and-cash transaction with no obvious antitrust footprint. CFIUS is the only material risk, and Shield AI is a U.S.-domiciled, U.S.-controlled buyer. Expect the close to land in late summer 2026, on schedule.
2. The X-BAT VTOL fighter jet flies in 2026 and is positioned against Anduril’s Bolt-M and Switchblade 600. Shield AI unveiled the X-BAT in October 2025 and has telegraphed initial flights in 2026, with operational validation targeted for 2028. The configuration most consistent with current statements is a tube-launched, one-way attack platform with V-BAT-derived autonomy. Expect a Replicator-eligible price point.
3. A second CCA Increment 1 platform integrates Hivemind by mid-2027. The economics of the CCA program reward software portability. Either General Atomics’ YFQ-42A or a follow-on Increment 2 design will run Hivemind alongside (or instead of) bespoke autonomy. This is the lever that turns the $12.7B valuation into a software multiple.
4. Revenue exceeds $750 million in 2026 – above the $540M guide. The guidance is calibrated to underwrite, not impress. Aechelon’s contribution alone (closing mid-year) lifts the run rate, and the V-BAT order book has been growing faster than Shield AI publicly disclosed during the round.
5. Shield AI files an S-1 in 2027, targeting a Q1 2028 listing at $20–30 billion. The crossover-investor structure of the Series G all but requires a public exit on a 24–36 month horizon. Expect the IPO comparables to be Palantir on multiples and Anduril on narrative. The window opens when interest rates normalize and the CCA program clears its first production contract.
Risks: What Could Break the Thesis
The bear case has three legs. First, prime contractors – Lockheed, Northrop, RTX, Boeing – are quietly building or buying their own autonomy stacks. If Lockheed’s Skunk Works delivers a competitive autonomy product before Hivemind locks in a second airframe, Shield AI’s software multiple compresses. Second, the FY2027 budget environment is uncertain. A continuing resolution or a CCA program restructure could push contract awards into 2028, stretching Shield AI’s runway and forcing a flat or down round. Third, the Replicator initiative has not been a financial bonanza for the firms it has anointed. The DoD’s preference for low unit cost runs counter to Shield AI’s higher-margin software model, and a misalignment between Replicator economics and Shield AI’s pricing could leave the company sidelined on the very program it is best positioned to win.
There is also the geopolitical wildcard. Shield AI’s V-BAT operates in conflict zones globally; Brandon Tseng’s reluctance to confirm or deny Iran deployments hints at sensitivities. A high-profile loss-of-airframe incident, an export-control violation, or a disclosed deployment in a contested theater could all create board-level reputational risk for Advent and JPMorgan, neither of which are accustomed to defense-policy headlines.
Market Impact: Why This Round Reshapes the Pricing of Every Autonomy Startup
The downstream effect on private-market pricing is immediate. Skydio, the U.S. drone company that closed a $170 million round at $2.2 billion in late 2024, is reportedly back in market at a meaningfully higher mark. Helsing in Europe priced its July 2025 round at €5 billion (~$5.4 billion); a follow-on conversation post-Shield AI is reportedly being floated above €8 billion. Smaller autonomy players – Saronic in maritime, Mach Industries in propulsion, Vannevar Labs in intelligence – all benefit from the new Shield AI comp. The Series G also raises the bar for what investors expect at later stages: $500 million-plus rounds are now table stakes for autonomy companies that hit a real defense program of record.
Crossover investor activity is the most underappreciated signal. Advent and JPMorganChase Security and Resiliency Initiative writing checks into a private autonomy company is qualitatively different from venture-only rounds. It indicates that the institutional-quality LP base – pensions, sovereign wealth, insurance – has decided autonomous defense is investable at scale. That capital base is dramatically larger than the venture pool that funded the category from 2017 to 2024, and it pulls the asymptotic valuation ceiling on the sector higher than any prior cycle.
Frequently Asked Questions
How much did Shield AI raise in its Series G round?
Shield AI raised $1.5 billion in Series G primary equity at a $12.7 billion post-money valuation, announced March 26, 2026. The total capital event reaches roughly $2.25 billion when combined with $500 million in Blackstone-led fixed-return preferred equity and a $250 million delayed-draw facility.
Who led Shield AI’s Series G?
Advent International led the round, co-led by JPMorganChase’s Security and Resiliency Initiative. Blackstone provided $500 million in additional preferred equity. Advent Chairman David Mussafer joined Shield AI’s Board of Directors; JPMorgan’s Todd Combs joined as a Board Observer.
What is Shield AI’s revenue and valuation history?
Shield AI projects 2026 revenue above $540 million, more than 80% growth from an estimated 2025 base of roughly $300 million, up from about $267 million in 2024 per Sacra and NewMarketPitch data. The company’s valuation has gone from approximately $40 million at seed (2017) to $5.3 billion at the March 2025 Series F-1 to $12.7 billion at the March 2026 Series G – a 140% one-year increase that Angel Investors Network’s tracking of the deal, and its roughly $2.25 billion total capital-package tally, independently corroborated.
What is Hivemind and why does it matter?
Hivemind is Shield AI’s autonomy software stack – perception, planning, and learning modules that allow aircraft and other platforms to operate without GPS, communications, or remote pilots. It is the autonomy provider for Anduril’s YFQ-44A “Fury” under the U.S. Air Force Collaborative Combat Aircraft program, the single largest near-term opportunity in autonomous defense.
Why is Shield AI acquiring Aechelon Technology?
Aechelon Technology builds the high-fidelity simulation and synthetic-environment software used by the Pentagon’s Joint Simulation Environment. Shield AI is buying Aechelon to vertically integrate the simulation pipeline that trains Hivemind, gain access to recurring software-license revenue from the Navy and Air Force, and improve gross margins ahead of a future IPO. Final close of the Series G is contingent on regulatory approval of the acquisition.
How does Shield AI compare to Anduril Industries?
Anduril is roughly 3x Shield AI’s valuation ($37.95B vs $12.7B at last primary round) and roughly 7x its 2025 revenue ($2.15B vs ~$300M). The two companies are partners on the CCA program rather than direct competitors: Anduril supplies the Fury airframe; Shield AI supplies the Hivemind autonomy software running on it.
When will Shield AI go public?
Shield AI has not announced an IPO timeline. The crossover-investor structure of the Series G – Advent and JPMorgan as anchors – is consistent with a 2027 S-1 filing and a 2028 listing, contingent on continued revenue growth, the Aechelon close, and the CCA contract converting to a program of record.
The Bottom Line on Shield AI’s $12.7B Moment
Shield AI’s Series G is the moment defense AI stopped being a venture-capital category and became an institutional one. The 140% valuation step-up, the Aechelon acquisition, the crossover-investor anchors, and the CCA software win all point in the same direction: autonomy software for combat platforms is now an investable, large-cap private-market asset class. Whether Shield AI ends up as the Microsoft of autonomous defense, a Palantir-style sub-segment leader, or a niche software vendor swallowed by a prime contractor will be decided over the next 24 months by execution on Aechelon, Hivemind portability, and the FY2027 budget. The capital is in place. The contracts are signed. The next milestone is the program of record.
Primary sources and further reading: Shield AI’s official announcement at shield.ai; TechCrunch’s round coverage; Washington Technology’s deal report; Anduril Industries’ corporate site; Advent International at adventinternational.com; Blackstone at blackstone.com.
